UMP(00722) released its annual performance, with a shareholder profit of HKD 40.643 million, a decrease of 32.8% year-on-year.

UMP (00722) announced its annual results for the year ended June 30, 2024, with revenue of HK$748 million, a year-on-year increase of 2.9%; the profit attributable to owners of the company was HK$40.643 million, a year-on-year decrease of 32.8%; basic earnings per share were 5.08 HK cents, with a proposed final dividend of 2.00 HK cents per share. The increase in total revenue for the period was mainly due to growth in the enterprise healthcare solutions business and clinical medical services revenue, particularly from the revenue contributed by the newly opened imaging center in the past year. The decrease in profit for the year was primarily due to a decline in operating profit margin, a significant increase in depreciation and amortization, and the write-off of other intangible assets, offset by the reversal of over-profits recognized for financial assets guaranteed.